Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deric L Wheeler

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
The American Journal of Pathology|January 6, 2005
Overexpression of protein kinase C-{epsilon} in the mouse epidermis leads to a spontaneous myeloproliferative-like diseaseDeric L Wheeler, Peter J Reddig, Kristin J Ness, et al.
Carcinogenesis|November 21, 2015
Genetic deletion of TNFα inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas in PKCε transgenic mice via inhibition of cell survival signalsAshok Singh, Anupama Singh, Samuel J Bauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2009
Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cellsSergio Benavente, Shyhmin Huang, Eric A Armstrong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2022
Targeting HER3-dependent activation of nuclear AKT improves radiotherapy of non-small cell lung cancerMahmoud Toulany, Mari Iida, Konstanze Lettau, et al.
Cancer Biology & Therapy|June 14, 2013
Targeting AKT with the allosteric AKT inhibitor MK-2206 in non-small cell lung cancer cells with acquired resistance to cetuximabMari Iida, Toni M Brand, David A Campbell, et al.
Discovery Medicine|September 4, 2013
Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinomaChunrong Li, Toni M Brand, Mari Iida, et al.
Cancers|January 23, 2024
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, RecruitKourtney L Kostecki, Mari Iida, Bridget E Crossman, et al.
Seminars in Cell & Developmental Biology|January 26, 2016
Adaptive responses to antibody based therapyTamara S Rodems, Mari Iida, Toni M Brand, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 5, 2013
Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer modelsHanneke Stegeman, Johannes H Kaanders, Albert J van der Kogel, et al.
Neoplasia (New York, N.Y.)|June 30, 2012
Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibitionPaul A Clark, Mari Iida, Daniel M Treisman, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
The American Journal of Pathology|January 6, 2005
Overexpression of protein kinase C-{epsilon} in the mouse epidermis leads to a spontaneous myeloproliferative-like diseaseDeric L Wheeler, Peter J Reddig, Kristin J Ness, et al.
Carcinogenesis|November 21, 2015
Genetic deletion of TNFα inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas in PKCε transgenic mice via inhibition of cell survival signalsAshok Singh, Anupama Singh, Samuel J Bauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2009
Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cellsSergio Benavente, Shyhmin Huang, Eric A Armstrong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2022
Targeting HER3-dependent activation of nuclear AKT improves radiotherapy of non-small cell lung cancerMahmoud Toulany, Mari Iida, Konstanze Lettau, et al.
Cancer Biology & Therapy|June 14, 2013
Targeting AKT with the allosteric AKT inhibitor MK-2206 in non-small cell lung cancer cells with acquired resistance to cetuximabMari Iida, Toni M Brand, David A Campbell, et al.
Discovery Medicine|September 4, 2013
Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinomaChunrong Li, Toni M Brand, Mari Iida, et al.
Cancers|January 23, 2024
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, RecruitKourtney L Kostecki, Mari Iida, Bridget E Crossman, et al.
Seminars in Cell & Developmental Biology|January 26, 2016
Adaptive responses to antibody based therapyTamara S Rodems, Mari Iida, Toni M Brand, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 5, 2013
Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer modelsHanneke Stegeman, Johannes H Kaanders, Albert J van der Kogel, et al.
Neoplasia (New York, N.Y.)|June 30, 2012
Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibitionPaul A Clark, Mari Iida, Daniel M Treisman, et al.
Pageof 8